Further, the anti-inflammatory activity of SCGB3A2 was demonstrated by the intranasal administration of recombinant adenovirus expressing SCGB3A2 to the OVA-induced inflammation model mouse, in which forced airway expression of SCGB3A2 suppressed OVA-induced airway inflammation [15]. This evidence concerns the gene SCGB3A2 and inflammatory response.